ES2368089T3 - Derivados de 4-(3-benzoilaminofenil)-6,7-dimetoxi-2-metilaminoquinazolina. - Google Patents

Derivados de 4-(3-benzoilaminofenil)-6,7-dimetoxi-2-metilaminoquinazolina. Download PDF

Info

Publication number
ES2368089T3
ES2368089T3 ES07714569T ES07714569T ES2368089T3 ES 2368089 T3 ES2368089 T3 ES 2368089T3 ES 07714569 T ES07714569 T ES 07714569T ES 07714569 T ES07714569 T ES 07714569T ES 2368089 T3 ES2368089 T3 ES 2368089T3
Authority
ES
Spain
Prior art keywords
compound
salt
hydrate
dimethoxy
methylaminoquinazolin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
ES07714569T
Other languages
English (en)
Spanish (es)
Inventor
Kazuki Miyazaki
Kazutomi Kusano
Yasutaka Takase
Osamu Asano
Manabu Shirato
Hisashi Wakita
Naoto Ishii
Takao Saeki
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Eisai R&D Management Co Ltd
Original Assignee
Eisai R&D Management Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eisai R&D Management Co Ltd filed Critical Eisai R&D Management Co Ltd
Application granted granted Critical
Publication of ES2368089T3 publication Critical patent/ES2368089T3/es
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/70—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
    • C07D239/72—Quinazolines; Hydrogenated quinazolines
    • C07D239/78—Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in position 2
    • C07D239/84—Nitrogen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/517—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with carbocyclic ring systems, e.g. quinazoline, perimidine

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
ES07714569T 2006-02-21 2007-02-20 Derivados de 4-(3-benzoilaminofenil)-6,7-dimetoxi-2-metilaminoquinazolina. Active ES2368089T3 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2006043273 2006-02-21
JP2006043273 2006-02-21

Publications (1)

Publication Number Publication Date
ES2368089T3 true ES2368089T3 (es) 2011-11-14

Family

ID=42137992

Family Applications (1)

Application Number Title Priority Date Filing Date
ES07714569T Active ES2368089T3 (es) 2006-02-21 2007-02-20 Derivados de 4-(3-benzoilaminofenil)-6,7-dimetoxi-2-metilaminoquinazolina.

Country Status (17)

Country Link
JP (1) JP4778550B2 (pt)
KR (1) KR101278852B1 (pt)
AT (1) ATE517875T1 (pt)
BR (1) BRPI0708098B8 (pt)
CY (1) CY1112554T1 (pt)
DK (1) DK1992622T3 (pt)
ES (1) ES2368089T3 (pt)
HR (1) HRP20110604T1 (pt)
IL (1) IL193322A (pt)
JO (1) JO2726B1 (pt)
MY (1) MY146275A (pt)
NZ (1) NZ569936A (pt)
PT (1) PT1992622E (pt)
RS (1) RS51969B (pt)
RU (1) RU2431632C2 (pt)
SI (1) SI1992622T1 (pt)
TW (1) TWI404709B (pt)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8530654B2 (en) 2007-02-16 2013-09-10 Eisai R&D Management Co., Ltd. Crystals, amorphous substances or salts of methyl N-[3-(6,7-dimethoxy-2-methylaminoquinazolin-4-yl) phenyl] terephthalamic acid
ATE538102T1 (de) 2007-08-17 2012-01-15 Eisai R&D Man Co Ltd Verfahren zur herstellung eines chinazolinderivats
CN101687819B (zh) 2007-08-17 2013-03-20 卫材R&D管理有限公司 外用剂

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU661533B2 (en) * 1992-01-20 1995-07-27 Astrazeneca Ab Quinazoline derivatives
WO1999011658A1 (en) * 1997-08-29 1999-03-11 Proteus Molecular Design Ltd. Meta-benzamidine derivatives as serin protease inhibitors
AR015966A1 (es) * 1997-10-17 2001-05-30 Smithkline Beecham Corp Uso de un compuesto inhibidor de pde4 para la preparacion de un medicamento util para el tratamiento de prurito
JPH11209350A (ja) * 1998-01-26 1999-08-03 Eisai Co Ltd 含窒素複素環誘導体およびその医薬
AU2005223610B2 (en) * 2004-03-23 2008-05-29 Banyu Pharmaceutical Co., Ltd. Substituted quinazoline or pyridopyrimidine derivative

Also Published As

Publication number Publication date
BRPI0708098A2 (pt) 2011-05-17
KR20080094811A (ko) 2008-10-24
RU2008137654A (ru) 2010-03-27
CY1112554T1 (el) 2016-02-10
TW200812980A (en) 2008-03-16
IL193322A0 (en) 2009-05-04
KR101278852B1 (ko) 2013-07-01
DK1992622T3 (da) 2011-09-05
IL193322A (en) 2014-04-30
JP4778550B2 (ja) 2011-09-21
SI1992622T1 (sl) 2011-11-30
PT1992622E (pt) 2011-09-19
RU2431632C2 (ru) 2011-10-20
RS51969B (sr) 2012-02-29
JO2726B1 (en) 2013-09-15
HRP20110604T1 (hr) 2011-09-30
ATE517875T1 (de) 2011-08-15
BRPI0708098B8 (pt) 2021-05-25
MY146275A (en) 2012-07-31
JPWO2007097317A1 (ja) 2009-07-16
NZ569936A (en) 2010-07-30
BRPI0708098B1 (pt) 2019-08-06
HK1122025A1 (en) 2009-05-08
TWI404709B (zh) 2013-08-11

Similar Documents

Publication Publication Date Title
CN113024544B (zh) 一种含氰基并杂环化合物及其用途
JP5596139B2 (ja) 二置換フタラジンヘッジホッグ経路アンタゴニスト
AU2009241561B2 (en) Disubstituted phthalazine hedgehog pathway antagonists
WO2021027911A1 (zh) 新型螺环类K-Ras G12C抑制剂
WO2021190467A1 (zh) 含螺环的喹唑啉化合物
EP1992622B1 (en) 4-(3-benzoylaminophenyl)-6,7-dimethoxy-2- methylaminoquinazoline derivative
WO2019042444A1 (zh) 一类抑制并降解酪氨酸蛋白激酶alk的化合物
CN115028648B (zh) 三并环化合物及其药物组合物和应用
US9981946B2 (en) Pyridine-substituted 2-aminopyridine protein kinase inhibitors
CN101687819A (zh) 新型外用剂
ES2958528T3 (es) Macrociclos sustituidos útiles como inhibidores de quinasas
CN116375704B (zh) Krasg12c突变蛋白异喹啉酮类抑制剂的制备及其应用
US8530654B2 (en) Crystals, amorphous substances or salts of methyl N-[3-(6,7-dimethoxy-2-methylaminoquinazolin-4-yl) phenyl] terephthalamic acid
KR101278852B1 (ko) 4-(3-벤조일아미노페닐)-6,7-디메톡시-2-메틸아미노퀴나졸린 유도체
WO2023168740A1 (zh) 喹啉类化合物的新用途
HK1122025B (en) 4-(3-benzoylaminophenyl)-6,7-dimethoxy-2- methylaminoquinazoline derivative
CN102060875A (zh) 新型喹唑啉衍生物、制备方法和用途
AU2008215411B2 (en) Crystal, amorphous form and salt of methyl N-[3-(6,7-dimethoxy- 2-methylaminoquinazolin-4-yl)phenyl]terephthalamic acid
WO2023206655A1 (zh) 一种PI3Kδ抑制剂及其用途
CN121824556A (zh) Top1-parp1双靶点抑制剂及其制备方法和应用
CN118772107A (zh) Hdac抑制剂及其用途
BR112024018160B1 (pt) Derivado de uracila que apresenta atividade de inibição do crescimento viral
JPWO2008099887A1 (ja) メチルn−[3−(6,7−ジメトキシ−2−メチルアミノキナゾリン−4−イル)フェニル]テレフタラミックアシッドの結晶、非晶質体または塩